Legal Representation
Attorney
Jennifer S. Stachniak
USPTO Deadlines
Application History
42 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 8, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Apr 8, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Oct 23, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 12, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 11, 2023 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Sep 1, 2023 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Sep 11, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 1, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 2, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 28, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Feb 28, 2023 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Feb 28, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 3, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 1, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Sep 1, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Sep 1, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 10, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 8, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Feb 8, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Feb 8, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 28, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 26, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 26, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 26, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 2, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 21, 2021 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | Loading... |
| Oct 7, 2020 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Sep 8, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 8, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 19, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 5, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 5, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Aug 5, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 5, 2020 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 5, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jul 29, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 25, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 25, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 25, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 19, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| May 17, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 8, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Diagnostic preparations for scientific or research use; Reagent paper other than for medical purposes
Class 005
RNA-guided therapeutic pharmaceuticals for the treatment of diseases and medical conditions, namely, allergies, autoimmune diseases and disorders, autoinflammatory diseases and disorders, bacterial infections, mycoses, blood diseases and disorders, cancer, cardiovascular diseases and disorders, chromosomal diseases and disorders, congenital diseases and abnormalities, hereditary diseases and abnormalities, neonatal diseases and abnormalities, cognitive diseases and disorders, connective tissue diseases and disorders, digestive system diseases and disorders, diabetes, ear, nose, and throat diseases and disorders, endocrine system diseases and disorders, female urogenital diseases and disorders, female reproductive diseases and disorders, pregnancy complications, fungal infections, genetic diseases and disorders, gastro-intestinal diseases and disorders, hemic and lymphatic diseases and disorders, hereditary cancer syndromes, heart diseases and disorders, hormonal diseases and disorders, immune system diseases and disorders, immunodeficiency diseases and disorders, infectious disease, inflammatory diseases and disorders, kidney and urinary diseases and disorders, lung diseases and disorders, male reproductive diseases and disorders, male urogenital diseases and disorders, mouth diseases and disorders, musculoskeletal diseases and disorders, neoplasms, nervous system diseases and disorders, neurological diseases and disorders, neuropsychiatric diseases and disorders, nutritional and metabolic diseases, ocular diseases and disorders, otorhinolaryngologic diseases, parasitic infections, respiratory diseases and disorders, skin and connective tissue diseases, stomatognathic diseases and disorders, chemical imbalances, viral infections; diagnostic preparations for medical or veterinary purposes; Reagent paper for medical or veterinary purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, allergies, autoimmune diseases and disorders, autoinflammatory diseases and disorders, bacterial infections, mycoses, blood diseases and disorders, cancer, cardiovascular diseases and disorders, chromosomal diseases and disorders, congenital diseases and abnormalities, hereditary diseases and abnormalities, neonatal diseases and abnormalities, cognitive diseases and disorders, connective tissue diseases and disorders, digestive system diseases and disorders, diabetes, ear, nose, and throat diseases and disorders, endocrine system diseases and disorders, female urogenital diseases and disorders, female reproductive diseases and disorders, pregnancy complications, fungal infections, genetic diseases and disorders, gastro-intestinal diseases and disorders, hemic and lymphatic diseases and disorders, hereditary cancer syndromes, heart diseases and disorders, hormonal diseases and disorders, immune system diseases and disorders, immunodeficiency diseases and disorders, infectious disease, inflammatory diseases and disorders, kidney and urinary diseases and disorders, lung diseases and disorders, male reproductive diseases and disorders, male urogenital diseases and disorders, mouth diseases and disorders, musculoskeletal diseases and disorders, neoplasms, nervous system diseases and disorders, neurological diseases and disorders, neuropsychiatric diseases and disorders, nutritional and metabolic diseases, ocular diseases and disorders, otorhinolaryngologic diseases, parasitic infections, respiratory diseases and disorders, skin and connective tissue diseases, stomatognathic diseases and disorders, chemical imbalances, viral infections; Medical diagnostic reagents and assays for testing of body fluids
Class 044
Disease and pest control treatments for agriculture, namely, breeding and propagating genetically modified plants with increased disease resistance; performing diagnosis of diseases; Medical testing for diagnostic or treatment purposes; Providing medical information from a website; Providing a website featuring information in the field of the diagnosis and treatment of allergies, autoimmune diseases and disorders, autoinflammatory diseases and disorders, bacterial infections, mycoses, blood diseases and disorders, cancer, cardiovascular diseases and disorders, chromosomal diseases and disorders, congenital diseases and abnormalities, hereditary diseases and abnormalities, neonatal diseases and abnormalities, cognitive diseases and disorders, connective tissue diseases and disorders, digestive system diseases and disorders, diabetes, ear, nose, and throat diseases and disorders, endocrine system diseases and disorders, female urogenital diseases and disorders, female reproductive diseases and disorders, pregnancy complications, fungal infections, genetic diseases and disorders, gastro-intestinal diseases and disorders, hemic and lymphatic diseases and disorders, hereditary cancer syndromes, heart diseases and disorders, hormonal diseases and disorders, immune system diseases and disorders, immunodeficiency diseases and disorders, infectious disease, inflammatory diseases and disorders, kidney and urinary diseases and disorders, lung diseases and disorders, male reproductive diseases and disorders, male urogenital diseases and disorders, mouth diseases and disorders, musculoskeletal diseases and disorders, neoplasms, nervous system diseases and disorders, neurological diseases and disorders, neuropsychiatric diseases and disorders, nutritional and metabolic diseases, ocular diseases and disorders, otorhinolaryngologic diseases, parasitic infections, respiratory diseases and disorders, skin and connective tissue diseases, stomatognathic diseases and disorders, chemical imbalances, viral infections
Additional Information
Design Mark
The mark consists of a design of a magnifying glass with a design of a virus in the lens next to the word "DETECT".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
001
005
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"DETECT"